- Home
- LQDA vs AMC Comparison
LQDA vs AMC Comparison
Compare LQDA & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDA
- AMC
- Stock Information
- Founded
- LQDA 2004
- AMC 1920
- Country
- LQDA United States
- AMC United States
- Employees
- LQDA N/A
- AMC N/A
- Industry
- LQDA Biotechnology: Pharmaceutical Preparations
- AMC Movies/Entertainment
- Sector
- LQDA Health Care
- AMC Consumer Discretionary
- Exchange
- LQDA Nasdaq
- AMC Nasdaq
- Market Cap
- LQDA 1.4B
- AMC 1.2B
- IPO Year
- LQDA 2018
- AMC 2013
- Fundamental
- Price
- LQDA $14.92
- AMC $3.55
- Analyst Decision
- LQDA Strong Buy
- AMC Hold
- Analyst Count
- LQDA 8
- AMC 7
- Target Price
- LQDA $27.13
- AMC $3.92
- AVG Volume (30 Days)
- LQDA 2.1M
- AMC 14.8M
- Earning Date
- LQDA 05-08-2025
- AMC 05-07-2025
- Dividend Yield
- LQDA N/A
- AMC N/A
- EPS Growth
- LQDA N/A
- AMC N/A
- EPS
- LQDA N/A
- AMC N/A
- Revenue
- LQDA $14,144,000.00
- AMC $4,548,300,000.00
- Revenue This Year
- LQDA $224.65
- AMC $7.95
- Revenue Next Year
- LQDA $250.54
- AMC $6.09
- P/E Ratio
- LQDA N/A
- AMC N/A
- Revenue Growth
- LQDA N/A
- AMC N/A
- 52 Week Low
- LQDA $8.26
- AMC $2.45
- 52 Week High
- LQDA $19.41
- AMC $5.96
- Technical
- Relative Strength Index (RSI)
- LQDA 45.94
- AMC 63.77
- Support Level
- LQDA $13.94
- AMC $2.88
- Resistance Level
- LQDA $17.88
- AMC $4.08
- Average True Range (ATR)
- LQDA 1.40
- AMC 0.26
- MACD
- LQDA -0.33
- AMC 0.08
- Stochastic Oscillator
- LQDA 17.92
- AMC 62.41
About LQDA Liquidia Corporation
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.